Summit Therapeutics
0 sources
Financials
0001599298-25-000048Summit Therapeutics
Summary
Summit Therapeutics is a public company[1].
Key Facts
- Summit Therapeutics's field of work was biopharmaceutical[2].
- Summit Therapeutics is in the country of GB[3].
- Summit Therapeutics's instance of is recorded as public company[4].
- Summit Therapeutics's headquarters location is recorded as Menlo Park[5].
- Summit Therapeutics's stock exchange is recorded as Nasdaq[6].
- 2003 marks the founding of Summit Therapeutics[7].
- Summit Therapeutics's official website is recorded as https://www.summittxinc.com/[8].
- Summit Therapeutics's legal form is recorded as B6ES[9].
Product Details
The following facts are restated verbatim from public-domain and CC0 open-data sources — every line is independently verifiable against the named source's catalog.
GLEIF Golden Copy — Level 1 entity data
-
Legal Entity Identifier (LEI): 213800NRW8AOMYMTBD89[10]
-
Registered legal name: Summit Therapeutics PLC[11]
-
Legal jurisdiction: GB[12]
-
GLEIF entity category: GENERAL[13]
-
Legal form (ISO 20275 ELF): B6ES[14]
-
Entity status: ACTIVE[15]
-
LEI registration status: LAPSED[16]
-
LEI first registered: 2017-01-04[17]
-
LEI last updated: 2021-01-08[18]
-
LEI next renewal: 2021-01-07[19]
-
Managing LOU: 213800WAVVOPS85N2205[20]
-
Registration authority: RA000585[21]
-
Authority entity ID: 05197494[22]
-
Other names: Summit Corporation PLC[23]
-
Conformity flag: NON_CONFORMING[24]
Body
Founding
2003 marks the founding of Summit Therapeutics[7].
Operations
Summit Therapeutics's headquarters location is recorded as Menlo Park[5].
Industry
Summit Therapeutics's field of work was biopharmaceutical[2].
Ownership
Summit Therapeutics's stock exchange is recorded as Nasdaq[6].